Emerging data suggest Retatrutide , a dual agonist targeting both the gut-brain axis and GIP , may offer a notable step forward for weight loss . Initial patient trials have shown impressive decreases in abdominal fat , potentially outperforming current weight-loss therapies . Nevertheless retatrutide weight lose , more evaluation is needed to comp